Imagine a place where data is eminent, where experts are seamless extensions to clinical teams, where people care about what they are doing and understand the impact they are having on humanity and where everything revolves around meeting client needs and exceeding expectations.
Welcome to Quanticate.
Statistical services have always been a key component of Quanticate's services as part of our heritage.
As an integral function within Biometrics, Quanticate programmers have supported clinical trials since 1994.
Quanticate's CDM team offer CRF design, database design, edit checks, discrepancy management, and coding of AEs and medications.
Our medical writing services include clinical and regulatory writing.
Quanticate offers a range of PV services throughout all phases of clinical trials as well as post-marketing.
Having so many experts within Quanticate provides us with the opportunity to provide real value to our clients.
With tightening budgets in clinical research and development it can be a challenge to find solutions that provide access to expert knowledge and still meet the budgets that have been approved. Typical challenges include managing overheads on internal resource, dealing with the highs and lows of work in your pipeline and not having enough experts available in-house or via partners to handle, process and provide input into the clinical data. These are all typical challenges that we have developed solutions to help resolve.
"Having worked as a statistician in a large pharmaceutical company, I could see an opportunity to create a company focused on providing expert statistical and statistical programming services. 22 years later, the company has become Quanticate and I am proud to say that Quanticate has become a global leader in providing data-related CRO services to the pharmaceutical, biotechnology and medical device industry. Throughout this time, I have focused on quality and I am pleased to see that we still receive many testimonials from customers confirming that our quality is industry leading. The reason for this success is directly attributed to our employee’s who are committed to developing long term partnerships and adding true value to the clinical teams that they support. They embrace our focus on being ‘The Data Experts’ and live our values of customer excellence, team work, integrity, and accountability on a daily basis. We want our customers and employees to be happy working with Quanticate and we will continue to strive for happy customers and employees through quality and expertise as we move forward.”
CEO & Chairman of the Board
Head of Division
Top 20 Pharmaceutical Company
Today, mHealth, Mobile Health, Mobile Apps and Wearables are hot topics with consumers and regulators alike. We're also starting to see consumer-grade wearables and mHealth technologies creeping into clinical trials. We've written this blog for those looking to use this area more. First, why are we...
We recently hosted a webinar on the challenges of Pharmacovigilance in early phase clinical trials. During the registration process we had the chance to survey members of the industry, 70% of the respondents were from pharmaceutical, biotechnology or medical device companies. We wanted to present...
This free webinar looks at the challenges of pharmacovigilance in early phase clinical trials. We demonstrate the importance of PV in early phase clinical trials and how it is not just a check box exercise to satisfy regulatory bodies
This paper describes current regulatory requirements with regards to patient safety narratives. It details a proposed process for their development and review and examines ways to lessen the burden of time and cost.
This paper reviews the different approaches to sourcing in clinical development. Quanticate is seeing a wide range of sourcing scenarios and this paper assesses these different strategies.